Drug Type Small molecule drug |
Synonyms 4-amino-4-deoxypteroylglutamate, 4-amino-PGA, 4-aminofolic acid + [13] |
Target |
Action inhibitors |
Mechanism DHFR inhibitors(Dihydrofolate reductase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H20N8O5 |
InChIKeyTVZGACDUOSZQKY-LBPRGKRZSA-N |
CAS Registry54-62-6 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D02527 | Aminopterin | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Plaque psoriasis | Phase 2 | United States | 01 Nov 2018 | |
| Rheumatoid Arthritis | Phase 2 | Ukraine | 01 Feb 2013 | |
| Recurrent Endometrial Cancer | Phase 2 | United States | 01 Jan 1998 | |
| Refractory Acute Leukemia | Phase 2 | United States | 01 Jul 1997 | |
| Refractory Leukemia | Phase 2 | United States | 01 Jul 1997 |
Phase 2 | 19 | (LD-Aminopterin Oral Capsule) | illwfazhtf = nnkynwtenh xzhvminzhx (swhrreqegx, guiiqmcysj - uqqiwqqpmq) View more | - | 14 Apr 2023 | ||
Placebo oral capsule (Placebo Oral Capsule) | illwfazhtf = pgdvjsqzsm xzhvminzhx (swhrreqegx, yqgtjpujal - lhhcqcjcev) View more | ||||||
Phase 2 | 60 | vkonerbtqw = twlntijrfw mislizngak (xgfuodthwg, zefdhkvahz - iqksglncjz) View more | - | 09 Jun 2014 | |||
L-asparaginase+Leucovorin+dexamethasone+Hydrocortisone+6-mercaptopurine+Methotrexate+vincristine+Cytarabine+daunomycin (Arm 1 Standard Risk) | fpuwbimcwk(piybcukisz) = awkjhinvks gbajycpedy (vkudexpepj, rbmatsuyro - hmrdczzlvq) View more |





